ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 256 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32 | 0.0% | 905 | 0.0% | 0.00% | – |
| Q2 2023 | $32 | -100.0% | 905 | -58.7% | 0.00% | – |
| Q1 2022 | $101,000 | -39.2% | 2,192 | -17.4% | 0.00% | -100.0% |
| Q3 2021 | $166,000 | -62.3% | 2,655 | -50.0% | 0.00% | 0.0% |
| Q2 2021 | $440,000 | +25.0% | 5,310 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $352,000 | -84.3% | 5,310 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $2,241,000 | +509.0% | 5,310 | -37.7% | 0.00% | 0.0% |
| Q3 2020 | $368,000 | +1169.0% | 8,530 | +2032.5% | 0.00% | – |
| Q2 2020 | $29,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |